CERo Therapeutics Holdings
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Total operating expenses were $2,932,985.
Profit Margin
| 2023 | 0 | -2.53K |
|---|
CERO Income Statement (2023 – 2023)
| 2023 | |
|---|---|
Revenue | |
Revenue | 0 |
Cost of revenue | 0 |
Gross profit | 0 |
Operating exp. | |
Research and development | 0 |
Selling and marketing | 2.89M |
Total operating expenses | 2.93M |
Operating income | -2.93M |
Other income (expenses), net | 491.57K |
Income before tax | -2.44M |
Income tax expense | 94.81K |
Net income | -2.53K |
Earnings per share | |
Basic EPS | -0.39 |
Diluted EPS | -0.39 |